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Background: Human immunodeficiency virus (HIV) pandemic is among the greatest health crises ever faced by
humanity. Morbidity and mortality in HIV disease is due to immunosuppression leading to life-threatening opportunistic
infections (OIs) during the natural course of the disease. This study was aimed to assess the prevalence and CD4
correlates of OIs among adult HIV-infected patients attending at Gondar University Hospital.
Methods: Cross sectional study was conducted on 360 adult HIV-infected patients attending antiretroviral therapy
clinic from February 2012-April 2012. Patients’ OI status was determined through clinical diagnosis and laboratory
investigations. CD4 count was determined using flow cytometry technique. Sociodemographic and clinical
data were obtained from interview and patients’ medical records. Bivariate and multivariate logistic regression
analysis was done using SPSS version 16 statistical soft ware and odds ratio was used as the measure of association.
P-value less than 0.05 was considered statistically significant for all tests.
Results: In this study, 360 HIV-infected patients were included; of whom (n = 216/360, 60%) were females. The
majority of patients (n = 153/360, 42.5%) were 25-34 years old with mean age of 35.5+ 8.8 standard deviation.
The overall prevalence of OIs was (n = 71/360, 19.7%). Tuberculosis (n = 35/360, 9.72%) followed by oral candidiasis
(n = 18/360, 5%) and diarrhea (n = 12/360, 3.3%) were the most frequently observed OIs. CD4 count less than
200/mm3 (OR = 4.933, P < 0.001), World Health Organization (WHO) clinical stage III (OR = 9.418, P < 0.001) and IV
(OR = 22.665, P < 0.001) were found to have strong association with acquisition of OIs.
Conclusions: Tuberculosis, oral candidiasis and diarrhea were the leading OIs encountered by HIV-infected patients.
CD4 count less than 200/mm3 and advanced WHO clinical stages of the disease were found to be predictors of OIs.
Interventions aimed at preventing and treating HIV associated OIs are crucial. Initiation of ART before the CD4
count drops below 350 should be encouraged.
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Human Immunodeficiency Virus (HIV) pandemic is among
the greatest health crises ever faced by humanity. Globally,
34.0 million people were living with HIV at the end of 2011
[1]. Sub-Saharan Africa remains most severely affected, with
nearly 1 in every 20 adults (4.9%) living with HIV [1]. In
Ethiopia, approximately one million people are living with
HIV which has become the leading cause of mortality
among 15-49 years of age, that accounts for about 43% of all
population in 2008 [2].
Morbidity and mortality in HIV disease result due to
underlying immunosuppression which leads to life-
threatening opportunistic infections (OIs) during the
natural course of the disease [3]. the widespread use of
ART starting in the mid-1990s has had the most profound
influence on reducing OI-related mortality in HIV-
infected persons in those countries in which these
therapies are accessible and affordable [4,5]. However,
OIs continue to cause morbidity and mortality in HIV/
AIDS patients even after ART. Some patients do not
have a sustained response to antiretroviral agents for
multiple reasons including poor adherence, drug toxic-
ities, drug interactions, or initial acquisition of a drug-
resistant strain of HIV-1. Therefore OIs continue to
cause substantial morbidity and mortality in patients
with HIV-1 infection despite use of ART [6].
Despite the fact that different studies have been con-
ducted on the prevalence of individual OIs among HIV-
infected patients in developing countries like Ethiopia,
information about the magnitude and spectrum of OIs
and their CD4 correlates is scarce in the study area.
Therefore, this study was aimed to add updates to the
existing data on extent of OIs and their immunological
correlates among HIV-infected patients attending ART
clinic of the Gondar University Hospital.
Methods
Study design and period
Institution based cross sectional study was conducted
among adult HIV-infected patients attending at ART
clinic of University of Gondar Hospital from February
2012-April 2012.
Study population and study area
The study population was all registered adult HIV-infected
patients attending ART clinic of Gondar University Hos-
pital for medical attention and consultation during the
study period. Study participants were screened for OIs only
once during the study period. The study was conducted at
the Gondar University Hospital ART clinic. The University
Hospital is a teaching Hospital situated in Gondar town,
737 Km away from the capital Addis Ababa with a pro-
jected population of 248,784 (Zonal statistics office). The
Hospital gives different inpatient and outpatient services tothe population in the surrounding area of Gondar town
and the adjacent regions. There is ART clinic in the Hos-
pital which provides voluntary counseling and testing
(VCT), ART and diagnostic services. All HIV-infected pa-
tients attending the clinic are assessed for OIs. Moreover
patients are regularly followed for immunological, organ
function and hematological tests.Variables
Socio demographic characteristics, CD4 count, Prophy-
laxis history and WHO clinical stage of HIV-infected pa-
tients were considered as explanatory variables; while
opportunistic infection status of HIV-infected patients
was considered as outcome variables of this study.Sample size and sampling techniques
Sample size was calculated using single population pro-
portion formula [7]. A total of 360 HIV-infected patients
were included in the study considering 5% non response
rate. Study participants were selected through systematic
random sampling method among HIV-infected patients
visiting the ART clinic during the study period.Data collection procedure
Sociodemographic characteristics and other factors
Sociodemographic and other relevant data were col-
lected by nurses through interview and from patients’
medical records using structured data collection format.
Orientation and supportive supervision were given to
data collectors to maintain data quality.Diagnosis of OIs
The diagnosis of the diseases was done through clinical
examination and laboratory investigation by two physi-
cians and one Health Officer in charge of examining
patients at ART outpatient department as per Federal
Ministry of Health guideline for management of OIs
and ART [8]. The patients who had more than two
weeks of cough were considered for the tuberculosis
examination. The diagnosis of tuberculosis (TB) was
confirmed by microscopic examination of the sputum
using acid fast bacilli (Ziehl- Neelsen) staining followed by
chest radiogram when negative for microscopy. Diagnosis
of Extra Pulmonary Tuberculosis (EPT) was done through
physical examination followed by fine needle aspiration
(FNA) smear microscopy for acid fast bacilli (AFB) and
cytological examination. For the conformation of chronic
diarrhea, solely clinical presentations and stool wet mount
were considered and no other types of investigations
pertaining to the causal agents were investigated. Oral
candidiasis, skin fungal infections and other OIs were
diagnosed by clinical presentations of patients.
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The CD4+ cell count of HIV seropositive persons were es-
timated using FACSCalibur flow cytometer (Becton
Dickinson, California, USA). The results of CD4 count
was reported as absolute count of CD4 cells/mm3 of blood
from the FACSCalibur CD4 counting machine.
Data processing and analysis
The data was entered and analyzed using SPSS (version
16) statistical soft ware. Logistic regression analysis was
done for variables significant at bi-variant analysis and
odds ratio was used as the measure of association between
the dependent variable and the co-variants. P-value less
than 0.05 was considered statistically significance for all
tests.
Data quality management and ethical consideration
Federal Ministry of Health guideline for management of
OIs and ART was strictly followed during clinical assess-
ment of OIs to maintain data quality. The CD4 count
was done after running control beads to check whether
the CD4 counting machine was working properly or not.
Moreover data collector nurses were given supportive
supervision to maintain data quality.
Ethical approval was obtained from the School Research
and Ethical Review Committee, College of Medicine and
Health Sciences, University of Gondar. All OI positive
patients were given treatment at the ART clinic as per
the OI treatment guideline.
Results
Sociodemographic and clinical characteristics
In this study, 360 adult HIV-infected patients were in-
cluded; of whom (n = 216/360, 60%) were females. The ma-
jority of patients (n = 153/360, 42.5%) were in age group
25-34. The mean age of the study subjects was 35.5+ 8.8
standard deviation ranging from 19 to 72. According to
CD4 cell count/mm3 of blood, majority (n = 187/360,
51.9%) had CD4 count of >350 cells/mm3. Majority of
the study subjects were WHO clinical stage I (n = 273/
360, 75.8%) while least number of study subjects were
WHO clinical stage IV (n = 17/360, 4.7%). Most of the
study subjects were on ART and cotri-moxazole pre-
ventive therapy which account (n = 281/360, 78%) and
(n = 301/360, 83.6%) respectively [Table 1].
Prevalence of OIs
The overall prevalence of OIs was found to be (n = 71/
360, 19.7%). Tuberculosis emerged as the most frequent
infection to be associated with HIV infection in patients
across the total range of CD4+ followed by oral candid-
iasis among the spectrum of OIs observed. Tuberculosis
infection was found to be prevalent among (n = 35/360,
9.72%) of patients. Of these (n = 30/35, 85.71%) werepulmonary tuberculosis while extra pulmonary types ac-
count (n = 5/35, 14.29%). Majority (n = 22/30, 73.33%) of
the pulmonary tuberculosis patients were smear negative
while (n = 8/30, 26.66%) were smear positive pulmonary
TB patients. Oral candidiasis emerged as the second
most prevalent infection (n = 18/360, 5%) followed by
diarrheal diseases, skin fungal infection, pneumonia and
others with prevalence of (n = 12/360, 3.3%), (n = 6/360,
1.67%), (n = 5/360, 1.38%) and (n = 6/360, 1.67%) re-
spectively [Figure 1]. Among diarrheic patients (n = 3/12,
25%) were positive for parasitic investigations, two were
positive for larva of Strongyloid stercolaris and one posi-
tive for ova of Schistosoma mansonia. There were twelve
co-infections of different OIs observed [Table 2].
Opportunistic infections and CD4 levels
The prevalence of OIs was found to be highest (n = 41/
71, 57.7%) among HIV-infected patients with CD4 count
less than 200/mm3 followed by CD4 count 200-350/
mm3 and count above 350/mm3 with prevalence of (n =
14/102, 13.3%) and (n = 16/187, 8.6%) respectively. CD4
count less than 200/mm3 is found to have strong associ-
ation with acquisition of OIs (OR = 4.933, P < 0.001)
[Table 1]. Higher prevalence of tuberculosis (n = 21/71,
29.58%), diarrhea (n = 4/71, 5.63%), oral candidiasis (n =
16/71, 22.53%), skin fungal infections (n = 4/71, 5.63%),
pneumonia (n = 3/71, 4.22%) and others (n = 4/71, 5.63%)
were found in patients with CD4 count less than 200/mm3.
Each OI diagnosed showed strong association with CD4
count less than 200/mm3; oral candidiasis (OR = 27.20,
P < 0.001), tuberculosis (OR = 9.40, P < 0.001), skin fun-
gal infections (OR = 11.10, P = 0.008) and pneumonia
(OR = 8.21, P = 0.032) [Table 3].
Associated risk factors of OIs
The prevalence of OIs was comparable (p = 0.482) among
males (n = 31/144, 21.5%) and females (40/216, 18.5%). Al-
though no statistically significant association was observed
(P = 0.721), highest prevalence of OIs was depicted among
age group 55 and above (n = 3/11, 27.3%). As far as marital
status is concerned single and divorced study subjects
depicted higher prevalence (n = 20/65, 30.8%) and (n = 25/
86, 29.1%) respectively (P = 0.001). Almost similar preva-
lence of OIs was observed among different educational
levels (P = 0.977) [Table 1].
World Health Organization clinical stage VI and III
showed highest prevalence (n = 14/17, 82.4%) and (n =
32/51, 62.7%) while least prevalence was observed
among clinical stage I patients (n = 19/273, 7%). Sta-
tistically significant association was depicted between
prevalence of OIs and WHO clinical stage III (OR =
9.418, P < 0.001) and IV (OR = 22.665, P < 0.001). Preva-
lence of OIs was higher (OR = 1.106, P = 0.865) among
patients who were not on co-trimoxazole prophylaxis
Table 1 Socio demographic characteristics and logistic regression analysis of risk factors for OIs among HIV-infected
patients attending at ART clinic of Gondar University Hospital, February- April 2012
Characteristics N (%) OIs COR (P-value) AOR (P-value)
Yes (%) No (%)
Age
15-24 28 (7.8) 7 (25) 21 (75) 1.00 1.00
25-34 153 (42.5) 30 (19.6) 123 (80.4) 0.732 (0.517) 0.749 (0.649)
35-44 123 (34.2) 25 (20.3) 98 (79.7) 0.765 (0.568) 0.536 (0.358)
45-54 45 (12.5) 6 (13.3) 39 (86.7) 0.462 (0.211) 0.363 (0.231)
>/=55 11 (3.1) 3 (27.30) 8 (72.7) 1.125 (0.884) 0.317 (0.327)
Marital status
Single 65 (18.1) 20 (30.8) 45 (69.2) 1.00 1.00
Married 144 (40) 19 (13.20) 125 (86.8) 0.342 (0.003)* 0.445 (0.104)
Divorced 86 (23.9) 25 (29.1) 61 (70.9) 0.922 (0.821) 1.428 (0.492)
Separated 10 (92.7) 0 (0) 10 (100) _ _
Widow 55 (15.3) 7 (12.7) 48 (87.30 0.328 (0.022)* 0.698 (0.492)
CD4 count (cells/mm3)
<200 71 (19.7) 41 (57.7) 30 (42.3) 14.602 (<0.001)* 4.933 (<0.001)*
200-350 102 (28.3) 14 (13.7) 88 (86.3) 1.173 (0.723)
>350 187 (52) 16 (8.6) 171 (91.4) 1.7 (0.172) 1.00
WHO clinical stage
I 273 (75.8) 19 (7) 254 (93) 1.00 1.00
II 19 (5.3) 6 (31.6) 13 (68.4) 6.17 (0.001)* 3.005 (0.098)
III 51 (42.2) 32 (62.7) 19 (37.3) 22.517 (<0.001)* 9.418 (<0.001)*
IV 17 (4.7) 14 (82.4) 3 (17.6) 62.384 (<0.001)* 22.665 (<0.001)*
Co-trimoxazole prophylax
Yes 301 (83.6) 47 (15.6) 254 (84.4) 1.00 1.00
No 59 (16.4) 24 (40.7) 35 (59.3) 3.706 (<0.001)* 1.106 (0.865)
ART status
Pre-ART 79 (22) 35 (44.3) 44 (55.7) 3.414 (<0.001)* 2.0003 (0.093)
On-Art 281 (78) 36 (12.8) 245 (87.2) 1.00 1.00

























Figure 1 Common OIs at ART clinic of Gondar University Hospital, February-April 2012. Others: Acute herpes zoster attack, Acute
tonsillopharyngitis, Kaposi’s sarcoma and Molluscum contagiosum.
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Table 2 Co-infection of different OIs at ART clinic of
Gondar University Hospital, February-April 2012
Co-infection of OIs Frequency (%)
TB and oral candidiasis 6 (50)
TB and skin fungal infection 1 (8.33)
Diarrhea and oral candidiasis 2 (16.66)
Skin fungal infection and oral candidiasis 2 (16.66)
Diarrhea, oral candidiasis and skin fungal infection 1 (8.33)
Total 12 (100)
Table 3 Association of CD4 level with OIs at ART clinic of
Gondar University Hospital, February- April 2012
Type of OIs Positive N (%) Negative N (%) OR (P-value)
Tuberculosis
<200 21 (29.58) 50 (70.42) 9.40 (<0.001)*
200-350 6 (5.88) 96 (94.22) 1.40 (0.544)
>350 8 (4.28) 179 (95.72) 1.00
Total 35 (9.72) 325 (90.28)
Diarrhea
<200 4 (5.63) 67 (94.37) 3.66 (0.075)
200-350 5 (4.90) 97 (95.10) 3.16 (0.103)
>350 3 (1.60) 184 (98.40) 1.00
Total 12 (3.33) 348 (96.77)
Oral candidiasis
<200 16 (22.53) 55 (77.47) 27.20 (<0.001)*
200-350 0 (0.00) 102 (100) _
>350 2 (1.06) 185 (98.94) 1.00
Total 18 (5.00) 342 (95.00)
Skin fungal
infections
<200 4 (5.63) 67 (94.37) 11.10 (0.008)*
200-350 1 (0.98) 101 (99.02) 1.84 (0.662)
>350 1 (0.53) 186 (99.47) 1.00
Total 6 (1.67) 354 (98.33)
Pneumonia
<200 3 (4.22) 68 (95.78) 8.21 (0.032)*
200-350 1 (0.98) 101 (99.02) 1.84 (0.662)
>350 1 (0.53) 186 (99.47) 1.00
Total 5 (1.38) 355 (98.62)
Others
<200 4 (5.63) 67 (94.37) 11.10 (0.008)*
200-350 1 (0.98) 101 (99.02) 1.84 (0.662)
>350 1 (0.53) 186 (99.47) 1.00
Total 6 (1.67) 354 (98.33)
*Statistically significant association, OR = Odds ratio.
Damtie et al. BMC Research Notes 2013, 6:534 Page 5 of 7
http://www.biomedcentral.com/1756-0500/6/534(n = 24/59, 40.7%) compared to their counter parts
who were on co-trimoxazole prophylaxis (n = 47/301,
15.6%). Similarly the prevalence of OIs was higher
(OR = 2.003, P = 0.093) in ART-naïve patients (n = 35/
79, 44.3%) as compared to patients exposed to ART (n =
36/281, 12.8%). However, the difference was not statisti-
cally significant [Table 1].
Discussion
Although HIV is the initial causative agent for AIDS,
most of the morbidity and mortality seen in immuno-
compromised patients results from OIs that take advan-
tage of the lowered cellular and humoral defense of the
patient. The overall prevalence of OIs in the present
study was (n = 71/360, 19.7%) which is a bit lower than a
27.4% reported prevalence of OIs among new adult
AIDS cases at New York City Department of Health and
Mental Hygiene [9]. The difference in this finding might
be due to the difference in study subjects; the study in
New York City included symptomatic AIDS patients
while this study included both healthy and symptomatic
patients which possibly reduce the prevalence of OIs in
the present study. The finding is by far lower than stud-
ies conducted in Kolkata, India and Bahir Dar, Ethiopia
which documented 53.4% and 88.9% prevalence respect-
ively [10,11]. This difference might be explained by meth-
odological differences in selecting study subjects in case of
Bahir Dar city and difference in ascertainment of OIs in
case of the study in India.
The present study revealed that tuberculosis infection
followed by oral candidiasis and diarrheal diseases emerged
as the predominant OIs identified with prevalence of (n =
35/360, 9.72%), (n = 18/360, 5%) and (n = 12/360, 3.3%)
respectively. According to WHO’s 2007 report, the
prevalence of all forms of TB in Ethiopia was estimated
at 546 per 100,000 populations; which is far lower than
the finding of this study [12]. This implies that TB in-
fection is opportunistic among HIV-infected people
even in high TB burden countries including Ethiopia.
This finding is in line with studies from India which
revealed tuberculosis as a major OI identified [13-15].
However another study conducted in India revealed
that oral candidiasis (53.43%) followed by chronic diar-
rhea (47.05%) are the commonest OIs identified while
TB stands fourth with the prevalence of 35.29% [10].
Despite the similarity in the order of OIs in different
studies there is still a disparity in the magnitude of
each OI; this might possibly be explained by differences in
the prevalence of OIs in the general population or differ-
ences in the methodology and OI screening criteria used.
There were twelve co-infections of different OIs ob-
served. Of these, (n = 6/12, 50%) were tuberculosis and
oral candidiasis co-infections. Higher proportion of TB
and OC co-infection in this study might be explained by
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subjects. Dual and triple OIs were also reported from
study in India [10].
The hospital where this study was conducted initiates
antiretroviral therapy when the CD4 level of a patient
becomes below 200/mm3 of blood which is far lower
than the recommendation by WHO which increase sus-
ceptibility of HIV-infected individuals to OIs. In this
study HIV-infected patients with CD4 count less than
200/mm3 were found to be 4.9 times more likely to de-
velop OIs compared to the reference group patients with
CD4 count >350/mm3. This finding is concordant with
other studies from India which reported high risk of
developing OIs such as TB, Pneumocystis jiroveci pneumo-
nia, and cryptococcal meningitis among patients with CD4
counts <200 cells/mm3 [16-18]. The patients’ CD4 count
was also found to be associated with development of indi-
vidual OIs. Patients with CD4 count less than 200/mm3
are 9.4, 27.2, 11.1 and 8.2 times more likely to develop tu-
berculosis, oral candidiasis, skin fungal infections and
pneumonia respectively compared to the reference cat-
egory CD4 count >350/mm3. This finding sounds true
since CD4 cells play a central role in the activation of both
humoral and cellular immune response to fight against in-
fection. Hence, low CD4 count increases susceptibility to
OIs.
World Health Organization clinical stage III and IV
HIV-infected patients were 9.4 and 22.6 times more
likely to develop OIs compared to clinical stage I coun-
ter parts respectively. This finding is in agreement with
the studies from India and South Africa which depicted
that advanced clinical stage of the disease is significantly
associated with development of OIs among patients on
ART [19-21].
Limitations
Since the Hospital where this study was conducted does
not routinely perform culture for the diagnosis of OIs
due to unavailability of culture for OIs, this study was
limited to identify etiology of most of the OIs. Hence
majority of the OIs were screened clinically which may
affect the diagnostic accuracy.
Conclusions
In the presence of all diagnostic limitations mentioned
above, the overall frequency of OIs in this study was sig-
nificant. Tuberculosis followed by OC and diarrhea were
the major OIs encountered by HIV-infected patients.
CD4 count less than 200/mm3 and WHO clinical stage
III and IV were found to be strongly associated with
prevalence of OIs. Interventions aimed at preventing and
treating HIV associated OIs is crucial. Commencement of
ART should be encouraged before the patients’ CD4 count
drops below 350/mm3 since the local practice is differentfrom the WHO’s recommendation for the commence-
ment of ART which is CD4 count <200/mm3.
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